We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.9B
AUM Growth
+$1.29B
(+3%)
Cap. Flow
+$573M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$229M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$212M |
| 3 |
Snowflake
SNOW
|
+$211M |
| 4 |
Lam Research
LRCX
|
+$193M |
| 5 |
CME Group
CME
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$282M |
| 2 |
PepsiCo
PEP
|
+$239M |
| 3 |
Walmart Inc
WMT
|
+$236M |
| 4 |
General Motors
GM
|
+$223M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.57% |
| 2 | Healthcare | 13.05% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSAI
2851
Hesai Group
HSAI
$2.86B
| $43.9K | ﹤0.01% |
10,484
-52,945
| -83% | -$252K |
|
2852
Clean Energy Fuels
CLNE
$353M
| $43.4K | ﹤0.01% |
16,265
-22,794
| -58% | -$58.8K |
|
2853
Real Brokerage
REAX
$486M
| $40.6K | ﹤0.01% |
+10,000
| New | +$42K |
|
2854
Dakota Gold
DC
$824M
| $39.9K | ﹤0.01% |
15,640
+3,706
| +31% | +$9.86K |
|
|
RVPH
2855
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $39.8K | ﹤0.01% |
+1,553
| New | +$70.6K |
|
2856
Microvast
MVST
$296M
| $39.3K | ﹤0.01% |
+86,146
| New | +$38.7K |
|
|
CTV
2857
DELISTED
Innovid Corp.
CTV
| $38.9K | ﹤0.01% |
21,004
+21
| +0.1% | +$45 |
|
2858
Rafael Holdings
RFL
$111M
| $38.1K | ﹤0.01% |
26,811
-22,960
| -46% | -$36.3K |
|
2859
Citizens
CIA
$193M
| $35.9K | ﹤0.01% |
13,200
-5,598
| -30% | -$14.1K |
|
2860
Goldgroup Mining
GORO
$266M
| $34.7K | ﹤0.01% |
92,992
-65,393
| -41% | -$31.9K |
|
2861
American Shared Hospital Services
AMS
$10.1M
| $34.3K | ﹤0.01% |
10,723
| – | – |
|
2862
Compugen
CGEN
$244M
| $34.1K | ﹤0.01% |
20,287
-81,555
| -80% | -$170K |
|
|
NFGC
2863
New Found Gold
NFGC
$738M
| $33.8K | ﹤0.01% |
11,956
-2,267
| -16% | -$7.99K |
|
|
DZSI
2864
DELISTED
DZS Inc. Common Stock
DZSI
| $33K | ﹤0.01% |
28,169
-10,128
| -26% | -$13.8K |
|
2865
Lexicon Pharmaceuticals
LXRX
$1.03B
| $32.2K | ﹤0.01% |
19,156
-170,275
| -90% | -$305K |
|
2866
American Battery Technology Co
ABAT
$333M
| $32K | ﹤0.01% |
25,582
+12,045
| +89% | +$16.7K |
|
2867
LanzaTech Global Warrant
LNZAW
$3.04M
| $31.8K | ﹤0.01% |
167,269
+69,569
| +71% | +$15.1K |
|
2868
GigaMedia
GIGM
$15.9M
| $31.4K | ﹤0.01% |
24,120
| – | – |
|
2869
HeartCore Enterprises
HTCR
$3.94M
| $30.8K | ﹤0.01% |
2,204
-259
| -11% | -$4.3K |
|
2870
Verastem
VSTM
$626M
| $30.1K | ﹤0.01% |
10,085
-1,997
| -17% | -$16.5K |
|
|
AKTS
2871
DELISTED
Akoustis Technologies Inc
AKTS
| $29.8K | ﹤0.01% |
+226,229
| New | +$85.2K |
|
2872
Cumberland Pharmaceuticals
CPIX
$115M
| $29.6K | ﹤0.01% |
19,330
-13,100
| -40% | -$20.6K |
|
|
NAAS
2873
NaaS Technology Inc
NAAS
$56.3M
| $29.3K | ﹤0.01% |
+755
| New | +$163K |
|
|
UNIT
2874
PUT
Uniti Group
UNIT
$2.38B
| $29.2K | ﹤0.01% |
10,000
| – | – |
|
|
SY
2875
So-Young International
SY
$239M
| $28.7K | ﹤0.01% |
26,955
-700
| -3% | -$817 |
|
Similar funds
John Overdeck's Q2 2024 Portfolio in Review
As of Q2 2024, John Overdeck held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
- John Overdeck added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
- John Overdeck's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
- John Overdeck fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
- John Overdeck opened 479 new positions and closed 480 in Q2 2024.
- John Overdeck's portfolio value rose 3% quarter-over-quarter to $43.9B.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.